# Rasagiline

NDC: 62135-676
Generic name: Rasagiline
Labeler / Manufacturer: Chartwell RX, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20180727

FDA application: ANDA201892

## Active ingredients

- RASAGILINE MESYLATE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62135-676"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62135-676
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9168d62-814a-444f-9d70-11674def339d